Literature DB >> 3651563

Uranyl acetate induces gel phase formation in model lipid and biological membranes.

M Caffrey1, S J Morris, G W Feigenson.   

Abstract

The effect of uranyl acetate on the mesomorphic phase state of lipids in model membranes as well as in isolated biological membranes has been examined. As little as 0.8 mM (0.03% [wt/vol]) uranyl acetate induces a liquid crystal-to-gel phase transformation in egg phosphatidic acid, bovine brain phosphatidylserine, and in lysed chromaffin granule membranes. These results along with others in the literature indicate that the uranyl acetate used in samples for electron microscopy could alter membrane morphology.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3651563      PMCID: PMC1330015          DOI: 10.1016/S0006-3495(87)83239-3

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  15 in total

1.  Effects of cations on dipalmitoyl phosphatidylcholine/cholesterol/water systems.

Authors:  Y Inoko; T Yamaguchi; K Furuya; T Mitsui
Journal:  Biochim Biophys Acta       Date:  1975-11-17

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  X-ray scattering from labeled membranes.

Authors:  J Stamatoff; T Bilash; Y Ching; P Eisenberger
Journal:  Biophys J       Date:  1979-12       Impact factor: 4.033

4.  Soluble and membrane lectin-binding glycoproteins of the chromaffin granule.

Authors:  A L Cahill; S J Morris
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

5.  Perturbation of membrane structure by uranyl acetate labeling.

Authors:  V A Parsegian; R P Rand; J Stamatoff
Journal:  Biophys J       Date:  1981-03       Impact factor: 4.033

6.  Polypeptide clearing in model membranes: an analysis of the partition of gramicidin a' between cadmium ion induced gel and liquid-crystalline phases in vesicles of phosphatidic acid and phosphatidylcholine.

Authors:  G W Feigenson
Journal:  Biochemistry       Date:  1983-06-21       Impact factor: 3.162

7.  The chromaffin granule as a model for membrane fusion: implications for exocytosis.

Authors:  S J Morris; M J Costello; J D Robertson; T C Südhof; W F Odenwald; D H Haynes
Journal:  J Auton Nerv Syst       Date:  1983-01

8.  X-ray scattering studies of heavy atom bound erythrocyte membrane suspensions.

Authors:  J Stamatoff; T Bilash; Y Ching
Journal:  Biochem Biophys Res Commun       Date:  1980-04-29       Impact factor: 3.575

9.  Influence of metal ions on the phase properties of phosphatidic acid in combination with natural and synthetic phosphatidylcholines: an X-ray diffraction study using synchrotron radiation.

Authors:  M Caffrey; G W Feigenson
Journal:  Biochemistry       Date:  1984-01-17       Impact factor: 3.162

10.  Kinetics and mechanism of the lamellar gel/lamellar liquid-crystal and lamellar/inverted hexagonal phase transition in phosphatidylethanolamine: a real-time X-ray diffraction study using synchrotron radiation.

Authors:  M Caffrey
Journal:  Biochemistry       Date:  1985-08-27       Impact factor: 3.162

View more
  3 in total

1.  Chapter 4 - Reconstitution of membrane budding with unilamellar vesicles.

Authors:  Anna V Shnyrova; Joshua Zimmerberg
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

2.  Nuclear magnetic resonance and calorimetric study of the structure, dynamics, and phase behavior of uranyl ion/dipalmitoylphosphatidylcholine complexes.

Authors:  T H Huang; A Blume; S K Das Gupta; R G Griffin
Journal:  Biophys J       Date:  1988-07       Impact factor: 4.033

3.  Synaptotagmin-1 and Doc2b Exhibit Distinct Membrane-Remodeling Mechanisms.

Authors:  Raya Sorkin; Margherita Marchetti; Emma Logtenberg; Melissa C Piontek; Emma Kerklingh; Guy Brand; Rashmi Voleti; Josep Rizo; Wouter H Roos; Alexander J Groffen; Gijs J L Wuite
Journal:  Biophys J       Date:  2019-12-25       Impact factor: 4.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.